Skip to main content
Top
Published in: Critical Care 1/2011

Open Access 01-02-2011 | Research

Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study

Authors: Mònica Magret, Thiago Lisboa, Ignacio Martin-Loeches, Rafael Máñez, Marc Nauwynck, Hermann Wrigge, Silvano Cardellino, Emili Díaz, Despina Koulenti, Jordi Rello, EU-VAP/CAP Study Group

Published in: Critical Care | Issue 1/2011

Login to get access

Abstract

Introduction

Since positive blood cultures are uncommon in patients with nosocomial pneumonia (NP), the responsible pathogens are usually isolated from respiratory samples. Studies on bacteremia associated with hospital-acquired pneumonia (HAP) have reported fatality rates of up to 50%. The purpose of the study is to compare risk factors, pathogens and outcomes between bacteremic nosocomial pneumonia (B-NP) and nonbacteremic nosocomial pneumonia (NB-NP) episodes.

Methods

This is a prospective, observational and multicenter study (27 intensive care units in nine European countries). Consecutive patients requiring invasive mechanical ventilation for an admission diagnosis of pneumonia or on mechanical ventilation for > 48 hours irrespective of admission diagnosis were recruited.

Results

A total of 2,436 patients were evaluated; 689 intubated patients presented with NP, 224 of them developed HAP and 465 developed ventilation-acquired pneumonia. Blood samples were extracted in 479 (69.5%) patients, 70 (14.6%) being positive. B-NP patients had higher Simplified Acute Physiology Score (SAPS) II score (51.5 ± 19.8 vs. 46.6 ± 17.5, P = 0.03) and were more frequently medical patients (77.1% vs. 60.4%, P = 0.01). Mortality in the intensive care unit was higher in B-NP patients compared with NB-NP patients (57.1% vs. 33%, P < 0.001). B-NP patients had a more prolonged mean intensive care unit length of stay after pneumonia onset than NB-NP patients (28.5 ± 30.6 vs. 20.5 ± 17.1 days, P = 0.03). Logistic regression analysis confirmed that medical patients (odds ratio (OR) = 5.72, 95% confidence interval (CI) = 1.93 to 16.99, P = 0.002), methicillin-resistant Staphylococcus aureus (MRSA) etiology (OR = 3.42, 95% CI = 1.57 to 5.81, P = 0.01), Acinetobacter baumannii etiology (OR = 4.78, 95% CI = 2.46 to 9.29, P < 0.001) and days of mechanical ventilation (OR = 1.02, 95% CI = 1.01 to 1.03, P < 0.001) were independently associated with B-NP episodes. Bacteremia (OR = 2.01, 95% CI = 1.22 to 3.55, P = 0.008), diagnostic category (medical patients (OR = 3.71, 95% CI = 2.01 to 6.95, P = 0.02) and surgical patients (OR = 2.32, 95% CI = 1.10 to 4.97, P = 0.03)) and higher SAPS II score (OR = 1.02, 95% CI = 1.01 to 1.03, P = 0.008) were independent risk factors for mortality.

Conclusions

B-NP episodes are more frequent in patients with medical admission, MRSA and A. baumannii etiology and prolonged mechanical ventilation, and are independently associated with higher mortality rates.
Literature
1.
go back to reference Rello J, Mirelis B, Alonso C, Prats G: Lack of usefulness of blood cultures to diagnose ventilator-associated pneumonia. Eur Respir J. 1991, 4: 1020-PubMed Rello J, Mirelis B, Alonso C, Prats G: Lack of usefulness of blood cultures to diagnose ventilator-associated pneumonia. Eur Respir J. 1991, 4: 1020-PubMed
2.
go back to reference Rello J, Gallego M, Mariscal D, Soñora R, Valles J: The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997, 156: 196-200.PubMedCrossRef Rello J, Gallego M, Mariscal D, Soñora R, Valles J: The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997, 156: 196-200.PubMedCrossRef
3.
go back to reference Luna CM, Videla A, Mattera J, Vay C, Famiglietti A, Vujacich P, Niederman MS: Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest. 1999, 116: 1075-1084. 10.1378/chest.116.4.1075.PubMedCrossRef Luna CM, Videla A, Mattera J, Vay C, Famiglietti A, Vujacich P, Niederman MS: Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest. 1999, 116: 1075-1084. 10.1378/chest.116.4.1075.PubMedCrossRef
4.
go back to reference DeRyke CA, Lodise TP, Rybak MJ, McKinnon PS: Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest. 2005, 128: 1414-1422. 10.1378/chest.128.3.1414.PubMedCrossRef DeRyke CA, Lodise TP, Rybak MJ, McKinnon PS: Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest. 2005, 128: 1414-1422. 10.1378/chest.128.3.1414.PubMedCrossRef
5.
go back to reference Gonzalez C, Rubio M, Romero-Vivas J, González M, Picazo JJ: Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis. 2003, 7: 102-108. 10.1016/S1201-9712(03)90004-X.PubMedCrossRef Gonzalez C, Rubio M, Romero-Vivas J, González M, Picazo JJ: Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis. 2003, 7: 102-108. 10.1016/S1201-9712(03)90004-X.PubMedCrossRef
6.
go back to reference Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J: Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med. 2007, 35: 2064-2070. 10.1097/01.CCM.0000277042.31524.66.PubMedCrossRef Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J: Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med. 2007, 35: 2064-2070. 10.1097/01.CCM.0000277042.31524.66.PubMedCrossRef
7.
go back to reference Kerdudou S, Laschke MW, Sinha B, Preissner KT, Menger MD, Hermann M: Fibronectin binding proteins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thromb Haemost. 2006, 96: 183-189.PubMed Kerdudou S, Laschke MW, Sinha B, Preissner KT, Menger MD, Hermann M: Fibronectin binding proteins contribute to the adherence of Staphylococcus aureus to intact endothelium in vivo. Thromb Haemost. 2006, 96: 183-189.PubMed
8.
go back to reference Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J, EU-VAP/CAP Study Group: Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med. 2009, 37: 2360-2368. 10.1097/CCM.0b013e3181a037ac.PubMedCrossRef Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, Diaz E, Topeli A, DeWaele J, Carneiro A, Martin-Loeches I, Armaganidis A, Rello J, EU-VAP/CAP Study Group: Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med. 2009, 37: 2360-2368. 10.1097/CCM.0b013e3181a037ac.PubMedCrossRef
9.
go back to reference Le Gall JR, Lemeshow S, Saulnier F: A new simplified physiology score (SAPS II) based on a European/North American multicentre study. JAMA. 1993, 270: 2957-2963. 10.1001/jama.270.24.2957.PubMedCrossRef Le Gall JR, Lemeshow S, Saulnier F: A new simplified physiology score (SAPS II) based on a European/North American multicentre study. JAMA. 1993, 270: 2957-2963. 10.1001/jama.270.24.2957.PubMedCrossRef
10.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874. 10.1097/00003246-199206000-00025.CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992, 20: 864-874. 10.1097/00003246-199206000-00025.CrossRef
11.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996, 22: 707-710. 10.1007/BF01709751.PubMedCrossRef Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996, 22: 707-710. 10.1007/BF01709751.PubMedCrossRef
12.
go back to reference American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005, 171: 388-416. 10.1164/rccm.200405-644ST.CrossRef American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005, 171: 388-416. 10.1164/rccm.200405-644ST.CrossRef
13.
go back to reference Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J: Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999, 160: 608-613.PubMedCrossRef Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J: Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med. 1999, 160: 608-613.PubMedCrossRef
14.
go back to reference Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R: Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest. 1995, 108: 786-788. 10.1378/chest.108.3.786.PubMedCrossRef Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R: Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest. 1995, 108: 786-788. 10.1378/chest.108.3.786.PubMedCrossRef
15.
go back to reference Bryan CS, Reynolds KL: Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis. 1984, 129: 668-671.PubMedCrossRef Bryan CS, Reynolds KL: Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis. 1984, 129: 668-671.PubMedCrossRef
16.
go back to reference Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax. 2004, 59: 130-135. 10.1136/thorax.2003.013888.PubMedPubMedCentralCrossRef Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T: Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax. 2004, 59: 130-135. 10.1136/thorax.2003.013888.PubMedPubMedCentralCrossRef
17.
go back to reference Menzies BE: The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis. 2003, 16: 225-229.PubMedCrossRef Menzies BE: The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis. 2003, 16: 225-229.PubMedCrossRef
18.
go back to reference Cheung AL, Krishnan M, Jaffe EA, Fischetti VA: Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest. 1991, 87: 2236-2245. 10.1172/JCI115259.PubMedPubMedCentralCrossRef Cheung AL, Krishnan M, Jaffe EA, Fischetti VA: Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest. 1991, 87: 2236-2245. 10.1172/JCI115259.PubMedPubMedCentralCrossRef
19.
go back to reference Shinbori T, Walczak H, Krammer PH: Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-α. Eur J Immunol. 2004, 34: 1762-1770. 10.1002/eji.200425097.PubMedCrossRef Shinbori T, Walczak H, Krammer PH: Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-α. Eur J Immunol. 2004, 34: 1762-1770. 10.1002/eji.200425097.PubMedCrossRef
20.
go back to reference Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C: Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy. 2007, 93: 214-236. full_text.PubMedCrossRef Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C: Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy. 2007, 93: 214-236. full_text.PubMedCrossRef
21.
go back to reference Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, Vogelaers DP, Decruyenaere JM, Colardyn FA: Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med. 2006, 34: 653-659. 10.1097/01.CCM.0000201405.16525.34.PubMedCrossRef Depuydt PO, Blot SI, Benoit DD, Claeys GW, Verschraegen GL, Vandewoude KH, Vogelaers DP, Decruyenaere JM, Colardyn FA: Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med. 2006, 34: 653-659. 10.1097/01.CCM.0000201405.16525.34.PubMedCrossRef
22.
go back to reference Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C: Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993, 94: 281-288. 10.1016/0002-9343(93)90060-3.PubMedCrossRef Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C: Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993, 94: 281-288. 10.1016/0002-9343(93)90060-3.PubMedCrossRef
23.
go back to reference Cisneros JM, Rodríguez-Baño J: Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002, 8: 687-693. 10.1046/j.1469-0691.2002.00487.x.PubMedCrossRef Cisneros JM, Rodríguez-Baño J: Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002, 8: 687-693. 10.1046/j.1469-0691.2002.00487.x.PubMedCrossRef
24.
go back to reference Rodriguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, Pascual A, Martínez-Martínez L, McQueary C, Actis LA, Vila J, Spanish Group for the Study of Nosocomial Infections (GEIH): Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008, 14: 276-278.PubMedCrossRef Rodriguez-Baño J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón J, Pascual A, Martínez-Martínez L, McQueary C, Actis LA, Vila J, Spanish Group for the Study of Nosocomial Infections (GEIH): Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008, 14: 276-278.PubMedCrossRef
25.
go back to reference Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J: Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med. 2003, 31: 2478-2482. 10.1097/01.CCM.0000089936.09573.F3.PubMedCrossRef Garnacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello J: Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med. 2003, 31: 2478-2482. 10.1097/01.CCM.0000089936.09573.F3.PubMedCrossRef
26.
go back to reference Wareham D, Bean D, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M: Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact if multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008, 27: 607-612. 10.1007/s10096-008-0473-y.PubMedCrossRef Wareham D, Bean D, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M: Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact if multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008, 27: 607-612. 10.1007/s10096-008-0473-y.PubMedCrossRef
27.
go back to reference Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M: The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect. 2006, 64: 282-287. 10.1016/j.jhin.2006.06.025.PubMedCrossRef Robenshtok E, Paul M, Leibovici L, Fraser A, Pitlik S, Ostfeld I, Samra Z, Perez S, Lev B, Weinberger M: The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect. 2006, 64: 282-287. 10.1016/j.jhin.2006.06.025.PubMedCrossRef
28.
go back to reference Jamulitrat S, Arunpan P, Phainuphong P: Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai. 2009, 92: 413-419.PubMed Jamulitrat S, Arunpan P, Phainuphong P: Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai. 2009, 92: 413-419.PubMed
29.
go back to reference Trouillet J, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998, 157: 531-539.PubMedCrossRef Trouillet J, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998, 157: 531-539.PubMedCrossRef
30.
go back to reference Blot S, Depuyct P, Vandewoude K, De Bacquer D: Measuring the impact of multi-drug resistance in nosocomial infection. Curr Opin Infect Dis. 2007, 20: 391-396. 10.1097/QCO.0b013e32818be6f7.PubMedCrossRef Blot S, Depuyct P, Vandewoude K, De Bacquer D: Measuring the impact of multi-drug resistance in nosocomial infection. Curr Opin Infect Dis. 2007, 20: 391-396. 10.1097/QCO.0b013e32818be6f7.PubMedCrossRef
31.
go back to reference Ibrahim EH, Ward S, Sherman G, Kollef MH: A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest. 2000, 117: 1434-1442. 10.1378/chest.117.5.1434.PubMedCrossRef Ibrahim EH, Ward S, Sherman G, Kollef MH: A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest. 2000, 117: 1434-1442. 10.1378/chest.117.5.1434.PubMedCrossRef
32.
go back to reference Niederman MS: Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med. 2001, 29: N114-N120. 10.1097/00003246-200104001-00011.PubMedCrossRef Niederman MS: Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med. 2001, 29: N114-N120. 10.1097/00003246-200104001-00011.PubMedCrossRef
33.
go back to reference Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH: Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006, 10: R97-10.1186/cc4946.PubMedPubMedCentralCrossRef Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH: Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care. 2006, 10: R97-10.1186/cc4946.PubMedPubMedCentralCrossRef
34.
go back to reference Menzies BE: The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis. 2003, 16: 225-229.PubMedCrossRef Menzies BE: The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis. 2003, 16: 225-229.PubMedCrossRef
35.
go back to reference Bodi M, Ardanuy C, Rello J: Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Crit Care Med. 2001, 29: N82-N86. 10.1097/00003246-200104001-00005.PubMedCrossRef Bodi M, Ardanuy C, Rello J: Impact of Gram-positive resistance on outcome of nosocomial pneumonia. Crit Care Med. 2001, 29: N82-N86. 10.1097/00003246-200104001-00005.PubMedCrossRef
36.
go back to reference Lisboa T, Diaz E, Sa-Borges M, Socias A, Sole-Violan J, Rodríguez A, Rello J: The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest. 2008, 134: 1208-1216. 10.1378/chest.08-1106.PubMedCrossRef Lisboa T, Diaz E, Sa-Borges M, Socias A, Sole-Violan J, Rodríguez A, Rello J: The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and health-care resources use in ventilator-associated pneumonia. Chest. 2008, 134: 1208-1216. 10.1378/chest.08-1106.PubMedCrossRef
Metadata
Title
Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study
Authors
Mònica Magret
Thiago Lisboa
Ignacio Martin-Loeches
Rafael Máñez
Marc Nauwynck
Hermann Wrigge
Silvano Cardellino
Emili Díaz
Despina Koulenti
Jordi Rello
EU-VAP/CAP Study Group
Publication date
01-02-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10036

Other articles of this Issue 1/2011

Critical Care 1/2011 Go to the issue